Literature DB >> 9473472

Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy.

R Ebensperger1, E Acevedo, J Meléndez, R Corbalán, M Acevedo, M Sapag-Hagar, J E Jalil, S Lavandero.   

Abstract

There is evidence that insulin-like growth factor-1 (IGF-1) plays a role in the development of left ventricular hypertrophy, but it is uncertain whether cardiac IGF-1 changes before or after hypertension is established, and whether circulating IGF-1 are involved in cardiac hypertrophy. We have investigated changes in circulating and left ventricular IGF-1 and in the expression of the IGF-1 gene in the left ventricles of rats during the development of hypertensive left ventricular hypertrophy (Goldblatt model; 2 kidney-1 clamped). Our results show that the left ventricular contents of IGF-1 and its mRNA were increased at one and four weeks of hypertension and hypertrophy, and that both returned to control values after nine weeks. These changes were unrelated to the seric concentration of IGF-1 in the blood. These results show that local rather than circulating IGF-1 levels contributed to the development of renovascular hypertensive left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473472     DOI: 10.1006/bbrc.1997.8031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Contribution of de novo protein synthesis to the hypertrophic effect of IGF-1 but not of thyroid hormones in adult ventricular cardiomyocytes.

Authors:  D Bell; B J McDermott
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Effects of tanshinone VI on insulin-like growth factor-1-induced hypertrophy of isolated cardiomyocytes from neonatal rats.

Authors:  Yuji Kawahara; Kouichi Tanonaka; Toru Arino; Toshiyuki Maki; Naoko Ishihara; Norio Takagi; Akira Yagi; Satoshi Takeo
Journal:  Exp Clin Cardiol       Date:  2004

Review 3.  Cardiovascular effects of growth hormone.

Authors:  W J Brickman; B L Silverman
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.